New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for pa ...

New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for ...

PHILADELPHIA, PA — Pennsylvania legislative leaders will facilitate a forward-looking discussion on medical cannabis at the ...

Study 1 was a double-blind, parallel design, placebo-controlled study that enrolled 473 patients randomized 1:1 to receive either ulixacaltamide or placebo for 12 weeks. The primary endpoint was the ...

Dr. Wilson seeks to develop and apply alternative, and low-cost, analytical techniques to the study of inborn errors of metabolism in order to improve access and availability to care for this patient ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming participation in the 20th European AIDS Conference (EACS) ...

A new analysis finds that evidence of constipation-fighting benefits is strongest for certain food, drinks, and supplements.

SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical ...

Given the unmet need of fatigue in primary biliary cholangitis (PBC), the PBC working group of the European Reference Network for Rare Liver Diseases assessed and summarised the current evidence ...

The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, ...

The FDA granted approval to nerandomilast, now Jascayd, for treating adults with idiopathic pulmonary fibrosis, marking the ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that it will participate in an ophthalmology panel at the upcoming 2025 Maxim Growth ...